Picture of Azenta logo

AZTA — Azenta News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Azenta Inc reports results for the quarter ended March 31 - Earnings Summary

Azenta Inc AZTA.OQ reported quarterly adjusted earnings of 5 cents​​ per share for the quarter ended March 31, identical to the same quarter last year.  The mean expectation of seven analysts for the quarter was for earnings of 7 cents per share. Wall Street expected results to range from 2 cents to 9 cents per share.

Revenue fell 9.9% to $143.42 million from a year ago; analysts expected $140.91 million.

Azenta Inc's reported EPS for the quarter was a loss of 88 cents​.

The company reported a quarterly loss of $40.46 million.

Azenta Inc shares had fallen by 26.6% this quarter and lost 49.2% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 22.5% in the last three months.​

In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 5 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "hold"

Wall Street's median 12-month price target for Azenta Inc is $45.00

This summary was machine generated from LSEG data May 7 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
Mar. 31 20250.070.05Missed
Dec. 31 20240.060.08Beat
Sep. 30 20240.100.18Beat
Jun. 30 20240.070.16Beat

Recent news on Azenta

See all news